The covid-19 pandemic period has been among the most challenging situations the world has ever come across because this situation was entirely uncertain, and we saw altogether a very new virus that was difficult to deal with. It spreads rapidly, and hence there is a need for better medication and treatment.
Molnupiravir Found To Be Effective For Treating Adult With Covid-19
But the continuous searches and efforts made by our scientists and healthcare professionals have made it possible, and we could tackle the situation well. However, things are much better for the people who have immunized themselves with the covid-19 vaccine. But critical problems may occur to those who are yet not vaccinated or immunized.
Several medicines have made the health care professional manage the conditions of the coronavirus well and save the lives of many individuals suffering from this virus. Among these many medicines, one of them is Molnupiravir. It is one of the antiviral medicines widely used since covid19. It is still in use and has been found to be very effective in recent studies.
Recent research was done on the Molnupiravir medicines to check their effectiveness against covid19 in the patience belonging to an adult group who are not yet vaccinated and suffer from Covid-19 spread. The research for obtaining more relevant results was done on a very random basis on people who had the least risk of getting covid-19 but were found to have been affected by the virus in the laboratory check.
There were around 1400+ individuals included in the research, among which half were suggested to take Placebo. In contrast, the other half were treated with Molnupiravir medicine a dose of two pills for five consecutive days was recommended to people.
The results of the research suggested that when both the category of people were evaluated, it was seen that seven individuals needed hospitalization and had suffered death within 29 days which have taken Placebo were as the individuals with the treatment of Molnupiravir medicine, among them it was only one individual who needed hospitalization and had suffered from death. So after this, it was concluded that almost half the number of individuals on treatment with Molnupiravir medicine had not suffered any complications.
When we look at the adverse effects of the medicines, it was found that the percentage was 33 for the placebo-treated individuals, whereas it was just 30 for Molnupiravir treated individuals. But still, these outputs have made Molnupiravir medicine more effective in use in the present time. So, several pharmaceuticals have tied up to Merck, the manufacturer of Molnupiravir, for more medicine production throughout the world.
The accompanying editor stated that “Vaccines must be the primary mode of protection against SARS-CoV-2; however, orally bio-available medications will become an essential tool for physicians in the management of this horrible disease,” so this is a relief that the vaccine is quite effective against this deadly virus. We can prevent ourselves if we take its shots within the time limit and as per the suggestion of our doctors.
We have a boon of medicines like Molnupiravir, which can prevent us from the drastic effects of the virus. This research is going to be very effective as it shows us the way how adults suffering from covid-19 can be treated effectively. We are fortunate that these medicines are present, but one should not show any carelessness towards preventing the disease. Also, the fact which shouldn’t be ignored is though adults are treated, they are also at much higher risk than any other age group as they are out for work. So any negligence shown by them can cost them their lives.
